Cite
MLA Citation
Johan F Vansteenkiste et al.. “Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.” Lancet oncology, vol. 17, no. 6, n.d., pp. 822–835. http://access.bl.uk/ark:/81055/vdc_100032476377.0x000059